The σ ligand JO 1784 prevents trimethyltin-induced behavioural and σ-receptor dysfunction in the rat

Pharmacology and Toxicology

Volumn 78, Issue 5, 1996, Pages 296-302

  O'Connell, Alan W ^a,b   Earley, Bernadette ^a   Leonard, Brian E ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; HALOPERIDOL; IGMESINE; PENTAZOCINE; RADIOLIGAND; SIGMA OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR STIMULATING AGENT; TRIMETHYLTIN; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; CONTROLLED STUDY; HIPPOCAMPUS; LIMBIC SYSTEM; LOCOMOTION; MALE; MAZE TEST; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PASSIVE AVOIDANCE; PEDUNCULAR ANSA; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; QUANTITATIVE ASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030008904     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb01378.x     Document Type: Article

References (51)

1. Aschner, M. & J. L. Aschner: Cellular and molecular effects of trimethyltin and triethyltin: relevance to organotin neurotoxicity. Neurosci. Behav. Rev. 1992, 16, 427-435.
2. 3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus. J. Pharmacol. Exp. Therap. 1993, 267, 961-970.
3. Brown, A. W., W. N. Aldridge, B. W. Street & R D. Verschoyle: The behavioural and neuropathologic sequelae of intoxication by trimethyltin compounds in the rat. Amer. J. Pathol. 1979, 97, 59-76.
4. Brown, A. W., R. D. Cavanagh, R. D., Verschoyle, M. F. Gysbers, H. B. Jones & W. N. Aldridge: Evolution of the intracellular changes in neurons caused by trimethyltin. Neuropath. Appl. Neurobiol. 1984, 10, 267-283.
5. Buresova, O. & J. Bures: Radial maze as a tool for assessing the effect of drugs on the working memory of rats. Psychopharmacology 1982, 77, 268-271.
6. Contreras, P., N. Gray, D. Ragan & T. Lathorn: BMY 14802 protects against ischaemia-induced neuronal damage in the gerbil. Life Sci. 1992, 51, 1143-1149.
7. Dyer, R. S., T. J. Walsh, W. F. Wonderlin & M. Berceglay: The trimethyltin syndrome in rats. Neurobehav. Toxicol. Teratol. 1982, 4, 127-133.
8. Earley, B., A. Biegon & B. E. Leonard: Quantitative autoradiographic analysis of muscarinic receptors and quantitative histochemistry of acetylcholinesterase in the rat brain after trimethyltin intoxication. Neurochem. Int. 1989, 15, 475-483.
9. Earley, B., M. Burke, B. E. Leonard, G.-F. Gouret & J. L. Junien: Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor. Brain Res. 1991, 546, 282-286.
10. Earley, B., M. Burke & B. E. Leonard: Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat brain. Neurochem. Int. 1992, 21, 351-366.
11. Earley, B., M. Canney, M. O'Neill, B. E. Leonard, C. Benicourt & J.-L. Junien: Experimental cerebral ischaemia in mongolian gerbils: Effects of JO 1784 on histological parameters and locomotor activity. Soc. Neurosci. Abst. 1993, 19, 1644.
12. Elben, U., B. Kitter & K. Rudolphi: Stroke therapy research: current trends. Drugs of Today 1992, 28, 333-351.
13. Foretemps, E., G. Amand, A. Bomboir, R. Lavwerys & E. C. Laterre: Trimethyltin poisoning: report of two cases. Int. Archs. Occup. Envir. Hlth. 1978, 4, 1-6.
14. Johnson, L. C. & V. J. DeNoble: N-methyl-D-aspartic acid (NMDA) induced convulsions: An in vivo model to identify NMDA antagonists. Soc. Neurosci. Abstr. 1988, 14, 241.
15. Junien, J.-L. & B. E. Leonard: Drugs acting on a and phencyclidine receptors: a review of their nature, function and possible therapeutic importance. Clin. Neuropharmacol. 1989, 12, 353-374.
16. 3H] acetylcholine release from rat hippocampus slices. Eur. J. Pharmacol. 1991, 200, 343-345.
17. 3H]-1-[1-(trienyl)-cyclohexyl]-piperidine. J. Pharmacol. Exp. Therap. 1986, 238, 739-748.
18. Lobner, D. & P. Lipton: σ ligands and noncompetitive NMDA antagonists inhibit glutamate relase during cerebral ischemia. Neurosci. Lett. 1990, 117, 169-174.
19. Lockhart, B. P., P. Soulard, C. Benicourt, A. Privat & J.-L. Junien: Distinct neuroprotective profiles for σ ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 1995, 675, 110-120.
20. Loo, P., A. Braunwalder, J. Lehman & M. Williams: Radioligand binding to central phencyclidine sites is dependent on excitatory amino acid receptor agonists. Eur. J. Pharmacol. 1986, 123, 467-468.
21. Lysko, P. G., T.-L. Yue, J. L. Gu & M. Feuerstein: Neuroprotective mechanism of (+) SKF 10,047 in vitro and in gerbil brain ischaemia. Stroke 1992, 23, 1319-1324.
22. 3H]TCP binding and NMDA receptors. Eur. J. Pharmacol. 1986, 123, 173-174.
23. Matsumoto, R. R., M. K. Hemstreet, N. L. Lai, A. Thurkauf, B. R. De Costa, K. C. Rice, S. B. Hellewell, W. D. Bowen & J. M. Walker: Drug specificity of pharmacological dystonia. Pharmacol. Biochem. Behav. 1990, 36, 151-155.
24. Matsumoto, R. R., W. D. Bowen, M. A. Tom, Y-N. Vo, D. D. Truong & B. R. De Costa: Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonism. Eur. J. Pharmacol. 1995, 280, 301-310.
25. McLean, S. & E. Weber: Autoradiographic visualization of haloperidol sensitive sigma receptors in guinea-pig brain. Neuroscience 1988, 25, 259-269.
26. Monnet, F. P., G. Debonnet, J.-L. Junien & C. de Montigny: N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors. Eur. J. Pharmacol. 1990, 179, 441-445.
27. 2 subtypes) and phencyclidine receptor density in the rat brain following trimethyltin intoxication. Neurochem. Int. 1994a, 25, 243-252.
28. O'Connell, A., B. Earley & B. E. Leonard: Effects of dextromethorphan on ibotenic acid-induced memory dysfunction in the rat. Med. Sci. Res. 1994b, 22, 349-350.
29. Olton, D. S. & R. J. Samuelson: Remembrance of places passed; spatial memory in rats. J. Exp. Psych. 1976, 2, 97-114.
30. O'Neill, M., B. Earley & B. E. Leonard: MK-801 and BMY 14802 protect against ischaemic-induced cell death in the gerbil hippocampus. Med. Sci. Res. 1994a, 22, 303-304.
31. O'Neill, M., B. Earley & B. E. Leonard: Dextromethorphan protects against ischaemia-induced hippocampal neurodegeneration in the gerbil. Med. Sci. Res. 1994b, 22, 337-338.
32. O'Neill, M., M. Caldwell, B. Earley, M. Canney, A. O'Halloran, J. Kelly, B. E. Leonard & J.-L. Junien: The σ receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia. Eur. J. Pharmacol. 1995, 283, 217-225.
33. Patel, M., B. K. Ardelt, G. K. W. Yim & G. E. Isom: Interaction of trimethyltin with hippocampal glutamate. Neurotoxicol. 1990, 11, 601-608.
34. Quirion, R., R. Chicheportiche, P. C. Contreras, K. M. Johnson, D. Lodge, S. W. Tam, J. H. Woods & S. R. Zukin: Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci. 1987, 10, 444-446.
35. Quirion, R., W. D. Bowen, Y. Itzhak, J.-L. Junien, J. M. Musacchio, R. B. Rothman, T.-P. Su, S. W. Tam & D. P. Taylor: A proposal for the classification of sigma binding sites. TiPS 1992, 13, 85-86.
36. Rainbow, T. C., W. V. Bleisch, A. Biegon & B. S. McEwen: Quantitative densitometry of neurotransmitter receptors. J. Neurosci. Methods 1982, 5, 127-138.
37. Roman, F., X. Pascaud, D. Vauche & J.-L. Junien: Evidence for a non-opioid sigma binding site in the guinea-pig myenteric plexus. Life Sci. 1988, 42, 2217-2222.
38. Roman, F., X. Pascaud, B. Martin, D. Vauche & J.-L. Junien: JO 1784, a potent and selective ligand for rat and mouse brain sigma sites. J. Pharm. Pharmacol. 1990, 42, 439-440.
39. 3H] ACh release by BMY 14802 and sabeluzole? FASEB J. 1990, 4, 330.
40. Simon, R. P., J. F. Swan, T. Griffiths & B. S. Meldrum: Blockade of N-methyl-D-aspartate receptors may protect against isehaemic damage in the brain. Science 1987, 226, 850-852.
41. Steinfels, G. F., G. P. Alberici, S. W. Tam & L. Cook: Biochemical, behavioral and electrophysiological actions of the selective sigma receptor ligand (+)pentazocine. Neuropsychopharmacol. 1988, 1, 321-327.
42. 3H] SKF 10,047 to etorphine inaccessible sites in guinea-pig brain. J. Pharmacol. Exp. Therap. 1982, 223, 284-290.
43. Su, T. P., S. E. Schell, F. Y. Ford-Rice & E. D. London: Steroid binding at σ receptors suggests a link between endocrine, nervous and immune systems. Science 1988, 240, 210-221.
44. 3H] haloperidol binding in guinea pig brain membrames. PANS 1984, 81, 5618-5621.
45. Taylor, D. P., J. P. Yevich, P. Dextrase, S. L. Moon, S. H. Behling, J. Defnet & M. Geissler: Sigma ligands: a role in neuroprotection? In: Multiple sigma and PCP receptors ligands: Mechanisms for neuromodulation and neuroprotection? Eds.: J. M. Kamenka & E. F. Domino. NPP Books, Ann Arbor, MI, 1992, 767-778.
46. Walker, J. M., R. R. Matsumoto, W. D. Bowen, D. L. Gans, K. D. Jones & F. O. Walker: Evidence for a role of haloperidol-sensitive sigma "opiate" receptors in the motor effects of antipsychotic drugs. Neurology 1988, 38, 961-965.
47. Walker, J. M., W. D. Bowen, F. O. Walker, R. R. Matsumoto, B. De Costa & K. C. Rice: Sigma receptors: biology and function. Pharmacol. Rev. 1990, 42, 355-397.
48. 3H] 1,2-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study. Brain Res. 1992, 581, 33-38.
49. Walsh, T. J., D. B. Miller & R. S. Dyer: Trimethylin, a selective limbic system neurotoxicant, impairs radial-arm maze performance. Neurobehav. Toxicol. Teratol. 1982, 4, 177-183.
50. Yamamoto, H., T. Yamamoto, N. Sagi, V. Klenerova, K. Goji, N. Kawai, A. Baba, E. Takamori & T. Moroji: Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via σ1 site. J. Neurosci. 1995, 15, 731-736.
51. Zukin, S. R., K. T. Brady, B. L. Slifer & R. L. Balster: Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors. Brain Res. 1984, 294, 174-177.